Biotech News

Biote Reports First Quarter 2026 Financial Results

biote Corp (BTMD)biote Corp2026-06-25 13:46 ESTEarnings

Sales team expansion on track and nearing targeted level Return to procedure growth expected in second half of 2026 First Quarter 2026 Financial Highlights Revenue of $44.9 million Gross profit margin of 68.9% Net income of $2.7 million and diluted earnings per share attributable to biote Corp.

Open original release

Related news

BTMDbiote Corp2026-06-25 13:46 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Names Rich Barrera to Board of Directors

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports Second Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call

BTMDbiote Corp2026-06-25 13:46 EST

Biote Reports Third Quarter 2025 Financial Results

BTMDbiote Corp2026-06-25 13:46 EST

Nearly 40% of Women Say They were Misdiagnosed During Perimenopause, National Survey Reveals

BTMDbiote Corp2026-06-25 13:46 EST

Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

View all latest news

biote Corp

biote is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

BTMDbiote Corp2026-06-26 11:29 EST

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer

BTMDbiote Corp2026-06-26 11:29 EST

Biote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEO

BTMDbiote Corp2026-06-26 11:29 EST

Biote Reports First Quarter 2026 Financial Results

BTMDbiote Corp2026-06-26 11:29 EST

Biote Reports First Quarter 2025 Financial Results

BTMDbiote Corp2026-06-26 11:29 EST

Biote Names Rich Barrera to Board of Directors

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States